Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07298395 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis (AD)

Interventions

DRUG: ENV-294
DRUG: Placebo

Sponsor

Enveda Therapeutics